These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2425297)

  • 21. Regulation of the binding of sigma- and phencyclidine (PCP)-receptor ligands in rat brain membranes by guanine nucleotides and ions.
    Itzhak Y; Khouri M
    Neurosci Lett; 1988 Feb; 85(1):147-52. PubMed ID: 2834673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium entry activators: distinct sites of dihydropyridine and aminopyridine action.
    Greenberg DA; Cooper EC; Carpenter CL
    Neurosci Lett; 1984 Sep; 50(1-3):279-82. PubMed ID: 6208517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A radiohistochemical measure of [3H]TCP binding to the activated NMDA-receptor-gated ion channel in rat brain.
    Hosford DA; Bonhaus DW; McNamara JO
    Brain Res; 1990 May; 516(2):192-200. PubMed ID: 1694710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that zinc inhibits N-methyl-D-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding.
    Yeh GC; Bonhaus DW; McNamara JO
    Mol Pharmacol; 1990 Jul; 38(1):14-9. PubMed ID: 1695316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restricted usefulness of tetraethylammonium and 4-aminopyridine for the characterization of receptor-operated K+-channels.
    Drukarch B; Kits KS; Leysen JE; Schepens E; Stoof JC
    Br J Pharmacol; 1989 Sep; 98(1):113-8. PubMed ID: 2553183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of 4-aminopyridine and 2,4-diaminopyridine on the in vivo release of acetylcholine and dopamine in freely moving rats measured by intrastriatal dialysis.
    Damsma G; Biessels PT; Westerink BH; De Vries JB; Horn AS
    Eur J Pharmacol; 1988 Jan; 145(1):15-20. PubMed ID: 2832183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of mono- and diaminopyridines on release of [3H]norepinephrine from isolated guinea-pig atrium.
    Sugimori T; Nagashima H; Vizi ES; Harsing LG; Chaudhry I; Lalezari I; Duncalf D; Goldiner PL; Foldes FF
    Neuropharmacology; 1987 Jun; 26(6):621-6. PubMed ID: 3037424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic characterization of the phencyclidine-N-methyl-D-aspartate receptor interaction: evidence for a steric blockade of the channel.
    Kloog Y; Haring R; Sokolovsky M
    Biochemistry; 1988 Feb; 27(3):843-8. PubMed ID: 2835078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of some pharmacological properties of 4-aminopyridine and 3,4-diaminopyridine in vivo.
    Houston T; Pleuvry BJ
    Br J Anaesth; 1984 Oct; 56(10):1139-42. PubMed ID: 6148094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
    Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embryonic and postnatal development of N-(1-[2-thienyl]cyclohexyl)[3H]piperidine binding sites in rat forebrain homogenates and slices.
    Shinohara K; Nishikawa T; Ishii S; Yamazaki K; Takahashi K
    Neurosci Lett; 1989 Dec; 107(1-3):307-12. PubMed ID: 2559372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of phencyclidine to rat brain membranes: technical aspect.
    Vincent JP; Vignon J; Kartalovski B; Lazdunski M
    Eur J Pharmacol; 1980 Nov; 68(1):73-7. PubMed ID: 6450049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [3H]PCP-3-OH and (+)[3H]SKF 10047 binding sites in rat brain membranes: evidence of multiplicity.
    Itzhak Y
    Eur J Pharmacol; 1987 Apr; 136(2):231-4. PubMed ID: 3036548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and properties of phencyclidine-binding sites in nervous tissues.
    Vincent JP; Bidard JN; Lazdunski M; Romey G; Tourneur Y; Vignon J
    Fed Proc; 1983 Jun; 42(9):2570-3. PubMed ID: 6303860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptors and secretory actions of sigma/phencyclidine agonists in anterior pituitary cells.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Dec; 121(6):2044-54. PubMed ID: 2824179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of sigma and PCP receptors after chronic administration of haloperidol and phencyclidine in mice.
    Itzhak Y; Alerhand S
    FASEB J; 1989 May; 3(7):1868-72. PubMed ID: 2541039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nitric oxide on L-[3H]glutamate binding to rat brain synaptic membranes.
    Fujimori H; Pan-Hou H
    Brain Res; 1991 Jul; 554(1-2):355-7. PubMed ID: 1657294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of dihydropyridine binding sites with calcium-dependent neurotransmitter release in synaptosomes.
    Massieu L; Tapia R
    J Neurochem; 1988 Oct; 51(4):1184-9. PubMed ID: 2458434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of [3H]phencyclidine and (+)-[3H]SKF-10,047 binding sites in rat cerebral cortex.
    Goldman ME; Jacobson AE; Rice KC; Paul SM
    FEBS Lett; 1985 Oct; 190(2):333-6. PubMed ID: 2995139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phencyclidine receptors in rat brain cortex.
    Mendelsohn LG; Kerchner GA; Kalra V; Zimmerman DM; Leander JD
    Biochem Pharmacol; 1984 Nov; 33(22):3529-35. PubMed ID: 6095851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.